We tailor these advanced GLP-1 receptor agonist therapies, including Ozempic, to each patient, ensuring individualized care that effectively supports diabetes management and cardiovascular risk reduction
Retatrutide is an investigational injectable medication under clinical development for the treatment of obesity and type 2 diabetes
With more late-stage clinical trial results forthcoming for this class of drugs, we will soon learn whether the promise of incretin-based therapies is justified
HbA1c, which reflects average glucose over 23 months, typically shows measurable reduction by 1216 weeks of treatment
Potential Benefits and Risks of Microdosing GLP-1 NHS Guidance on GLP-1 Use for Thyroid Conditions Speaking to Your GP About GLP-1 and Hashimoto's Scientific References Frequently Asked Questions What Is Microdosing GLP-1 and How Does It Work
doi: 10.1016/S2213-8587(17)30013-X